U.S. FDA Expands Indication for Roche ' s Bleeding Disorder Drug U.S. FDA Expands Indication for Roche ' s Bleeding Disorder Drug

Roche said on Thursday it received approval from U.S. regulators for its hemophilia A drug Hemlibra (emicizumab)for use in nearly all patients, as the Swiss drugmaker pushes deeper into diseases beyond cancer to replace revenue from older, patent-expired drugs.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news